Short Guide on Patient Partnerships in Rare Disease Research Projects – Basic, Pre-clinical, Translational & Social

1:1

publication

This practical “Short Guide on Patient Partnerships in Rare Disease Research Projects” was created by the European Joint Programme on Rare Diseases (EJP RD) to show scientists, funders and patient organisations how to build meaningful, two-way collaborations in basic, pre-clinical, translational and social-science studies.

It explains why early and sustained patient involvement boosts relevance, impact and funding success, and provides concrete examples, check-lists and real-life testimonials to help consortia avoid common pitfalls and design truly patient-centred projects.

Key publication details

• Full title: Short Guide on Patient Partnerships in Rare Disease Research Projects – Basic, Pre-clinical, Translational & Social
• Authors: Working Group “Patient Engagement in Biomedical Research Projects” (PENREP), chaired by EURORDIS and convened under the European Joint Programme on Rare Diseases (EJP RD).
• Scientific reviewers: Prof. Hanns Lochmüller (CHEO Research Institute, Canada) and Prof. Danny Huylebroeck (KU Leuven, Belgium).
• First publication date: July 2020
• Publisher/Imprint: European Joint Programme on Rare Diseases (EJP RD), Paris (FR).

Acces this publication (pdf)
Short-Guide-on-Patient-Partnerships-in-Rare-Disease-Research-Projects-Basic-Pre-clinical,-Translational-and-Social

Year of publication

2020

Author

Working Group “Patient Engagement in Biomedical Research Projects” (PENREP), chaired by EURORDIS and convened under the European Joint Programme on Rare Diseases (EJP RD).

You might also be interested in

RealiseD webinars

RealiseD Webinar Series: Helping re‑shape rare disease clinical trials

13 January – 10 February 2026 | Online webinar series to advance best practices in clinical trial design for rare and ultra rare diseases.
P065130-414294

Joining the Dots: EURORDIS’ role in ERDERA and the reshaping of rare disease research

EURORDIS champions patient-centred innovation in rare disease research
HLM Rare Diseases Brussels 2025

HLM Rare 2025 in Brussels: forging a European Declaration for rare and complex diseases

Three days in Brussels help advance the European Declaration on Rare and Complex Diseases
Emine Eylul Taksin

“By supporting more joint projects and research partnerships, Türkiye’s National Mirror Group can help ensure that the country’s scientific strengths translate into tangible benefits for patients”

ERDERA interviews Emine Eylül Taşkın, Project Manager at ERDERA and at the İzmir Biomedicine and Genome Center (IBG)

ERDERA's

search form